Research presented at the Global Embolization Symposium and Technologies US (GEST US meeting, 1–4 May, San Francisco, USA) meeting suggests that patients undergoing transhepatic interventions should have tract embolization performed to prevent haemorrhagic complications.
Over the years, we have seen a rapid development of tools, tricks and techniques that enable ablation of tumours located in regions that are in close proximity to thermally sensitive organs or structures. Despite this, what remains of paramount importance and central to ablating tumours, especially those that are deemed high-risk, is a complete understanding of the type of thermal injury applied, tissue properties of the target organ, electrode design, configuration of the isotherm created when applying one or several of these electrodes and, most importantly, a thorough understanding of anatomical structures that may inadvertently be in the ablative zone.
May 7, 2014—The US Food and Drug Administration (FDA) has issued a Safety Communication regarding removal of retrievable inferior vena cava (IVC) filters. The document, which contains no new safety concerns, updates a previously issued Initial Communication from August 2010 to include information on recently published research and postmarket surveillance studies for these devices.
A study presented at the Society of Interventional Radiology’s (SIR’s) 39th Annual Scientific Meeting (San Diego, USA) by Sam Stuart from Great Ormond Street Hospital for Children, London, UK, suggests that antegrade gastrostomy insertion in infants who are less than 5kg in weight, is technically feasible and safe.
The initial clinical experience is to be presented at the Global Embolization Symposium and Technologies US meeting (GEST US,1–4 May, San Francisco, USA), a press release says.
Preliminary observations from the trial were presented at the Global Embolization Symposium and Technologies US (GEST US meeting, 1–4 May, San Francisco, USA) and show increased tumour penetration with the Surefire system.
Interventional radiology techniques are widely performed and useful in liver metastases from neuroendocrine tumours, but the level of scientific proof is paradoxically low, especially when considering that these techniques are used in patients with cancer, write Maxime Ronot and Valérie Vilgrain.
The US$415 million cash acquisition is expected to strengthen Boston Scientific’s peripheral interventions business and accelerate growth in peripheral atherectomy and thrombectomy categories.
May 30, 2014—Veryan Medical, Ltd. announced that full 2-year data from the MIMICS study were presented at the 15th annual New Cardiovascular Horizons (NCVH) conference in New Orleans, Louisiana.
Seeking a second and third opinion reduced the number of hysterectomies carried out to treat uterine fibroids, according to a single-center study published in the open access Journal of Therapeutic Ultrasound.
A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna heard.
Shrinking the prostate without surgery can provide long-term relief to men with this common condition that causes annoying symptoms, such as frequent trips to the bathroom, suggests a study of nearly 500 men. According to research being presented at the Society of Interventional Radiology s 39th Annual Scientific Meeting, 72 percent of men experienced symptom improvement three years after having a new, minimally invasive, image-guided treatment performed by interventional radiologists called prostate artery embolization (PAE).
Imaging of the coronary arteries with computed tomography (CT) angiography provides an accurate assessment of arterial plaque and could have a dramatic impact on the management of diabetic patients who face a high risk of heart attacks and other cardiovascular events, according to a new multicenter study published online in the journal Radiology.
In a report of their proof of principle study in the Journal of Urology, researchers from the University of Tampere describe how the "eNose" successfully differentiated between prostate cancer and benign prostatic hyperplasia (BPH) by analyzing the "smell print" of the headspace of a urine sample (the air immediately above the urine).
Patients with peripheral arterial disease in the upper leg experienced significantly better outcomes at 12 months after treatment with the In.Pact Admiral drug-coated balloon (Medtronic) than with standard balloon angioplasty, according to a landmark clinical study reported for the first time at the Charing Cross Symposium (5–8 April, London, UK)
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos